Optimal vitamin B 12 status is important for vascular health. Vascular endothelial (VE) cad-herin is an adherent junction protein involved in the maintenance of a functional endothe-lium. We hypothesized that vitamin B 12 deficiency can negatively affect markers of vascular function, such as VE-cadherin. Within a human intervention study, we explored the possible association between cobalamin status (i.e., vitamin B 12 , holotranscobalamin, and homocys-teine) and VE-cadherin (as marker of vascular health) in vegetarians/vegans (VEG) with B 12 deficiency. The associations were evaluated at baseline and after 90-day supplementation with 2000 pg/wk of vitamin B 12 . On the whole, an inverse association between VE-cadherin and holotranscobalamin ( P = .014) and a positive association between VE-cadherin and ho-mocysteine ( P = .041) was documented at baseline. VEG women showed higher levels of VE-cadherin compared with VEG men ( P = .044), suggesting an increase in endothelial per-meability. The intervention with vitamin B 12 restored serum vitamin levels and improved the overall cobalamin status, whereas it did not affect VE-cadherin levels. The inverse asso-ciation between holotranscobalamin and VE-cadherin was also maintained after interven-tion in women, corroborating the strong correlation between these 2 parameters. The results obtained seem to suggest a possible association between cobalamin status and VE-cadherin even if the intervention with B 12 failed to positively affect VE-cadherin levels. Thus, further studies are needed to corroborate these findings and clarify the contribution of a vitamin B 12 intervention on VE-cadherin levels in this target population. This trial was registered at ISRCTN registry (ISRCTN75099618). (c) 2022 Elsevier Inc. All rights reserved.
Cobalamin status is negatively correlated with vascular endothelial-cadherin in vegetarian and vegan women with vitamin B12 deficiency / M. Marino, D. Martini, S. Ciappellano, A. Brusamolino, C. Gardana, A. Battezzati, P. Riso, M. Porrini, C. Del Bo'. - In: NUTRITION RESEARCH. - ISSN 0271-5317. - 105:(2022), pp. 126-137. [10.1016/j.nutres.2022.07.001]
Cobalamin status is negatively correlated with vascular endothelial-cadherin in vegetarian and vegan women with vitamin B12 deficiency
M. MarinoPrimo
;D. MartiniSecondo
;S. Ciappellano;A. Brusamolino;C. Gardana;A. Battezzati;P. Riso;M. PorriniPenultimo
;C. Del Bo'
Ultimo
2022
Abstract
Optimal vitamin B 12 status is important for vascular health. Vascular endothelial (VE) cad-herin is an adherent junction protein involved in the maintenance of a functional endothe-lium. We hypothesized that vitamin B 12 deficiency can negatively affect markers of vascular function, such as VE-cadherin. Within a human intervention study, we explored the possible association between cobalamin status (i.e., vitamin B 12 , holotranscobalamin, and homocys-teine) and VE-cadherin (as marker of vascular health) in vegetarians/vegans (VEG) with B 12 deficiency. The associations were evaluated at baseline and after 90-day supplementation with 2000 pg/wk of vitamin B 12 . On the whole, an inverse association between VE-cadherin and holotranscobalamin ( P = .014) and a positive association between VE-cadherin and ho-mocysteine ( P = .041) was documented at baseline. VEG women showed higher levels of VE-cadherin compared with VEG men ( P = .044), suggesting an increase in endothelial per-meability. The intervention with vitamin B 12 restored serum vitamin levels and improved the overall cobalamin status, whereas it did not affect VE-cadherin levels. The inverse asso-ciation between holotranscobalamin and VE-cadherin was also maintained after interven-tion in women, corroborating the strong correlation between these 2 parameters. The results obtained seem to suggest a possible association between cobalamin status and VE-cadherin even if the intervention with B 12 failed to positively affect VE-cadherin levels. Thus, further studies are needed to corroborate these findings and clarify the contribution of a vitamin B 12 intervention on VE-cadherin levels in this target population. This trial was registered at ISRCTN registry (ISRCTN75099618). (c) 2022 Elsevier Inc. All rights reserved.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0271531722000665-main.pdf
accesso riservato
Descrizione: Article
Tipologia:
Publisher's version/PDF
Dimensione
808.87 kB
Formato
Adobe PDF
|
808.87 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.